Sign Up to like & get
recommendations!
1
Published in 2021 at "Clinical pharmacology and therapeutics"
DOI: 10.1002/cpt.2346
Abstract: Increased interest in real-world evidence (RWE) for clinical and regulatory decision making and the need to evaluate long-term benefits and risks of pharmaceutical products raise the importance of understanding the use of external controls (ECs)…
read more here.
Keywords:
extensions clinical;
trials use;
clinical trials;
uncontrolled extensions ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Genetic Epidemiology"
DOI: 10.1002/gepi.22444
Abstract: Large‐scale sequencing and genotyping data provide an opportunity to integrate external samples as controls to improve power of association tests. However, due to the systematic differences between genotyped samples from different studies, naively aggregating the…
read more here.
Keywords:
rare variant;
power;
external controls;
variant ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Neuromuscular Disorders"
DOI: 10.1016/j.nmd.2022.02.009
Abstract: Using external controls based on real-world or natural history data (RWD/NHD) for drug evaluations in Duchenne muscular dystrophy (DMD) is appealing given the challenges of enrolling placebo-controlled trials, especially for multi-year trials. Comparisons to external…
read more here.
Keywords:
placebo;
drug;
world natural;
rwd nhd ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "PLoS Genetics"
DOI: 10.1371/journal.pgen.1007591
Abstract: A primary goal of the recent investment in sequencing is to detect novel genetic associations in health and disease improving the development of treatments and playing a critical role in precision medicine. While this investment…
read more here.
Keywords:
external controls;
association test;
case control;
proxecat proxy ... See more keywords